openPR Logo
Press release

Genetic Testing Market Expected to Grow at a CAGR over 11.5% Till 2024 with Worldwide Top Venders like Abbott Laboratories, Bio-Rad Laboratories, Inc., Illumina Inc., Myriad Genetics, Inc., PerkinElmer Inc., QIAGEN N. V., Quest Diagnostics Incorporated Et

07-29-2019 03:19 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Genetic Testing Market

Genetic Testing Market

Adoption of Non-Invasive Technology to Trigger Genetic Testing Market Says MRFR

Market Synopsis

Market Research Future (MRFR) asserts that the global genetic testing market is likely to garner USD 10,033.4 million by 2023, grabbing a CAGR of 9.8% during the forecast period (2017-2023). Detection and prevention of genetic diseases are favoring the market growth across the globe. Genetic testing is referred to as a type of medical test which analyzes the changes in proteins, chromosomes, and genes occurred by any disease or any suspected genetic condition. The test is usually performed on tumors in order to diagnose cancer and accordingly plan the treatment. It involves the use of laboratory procedures to examine the genes inherited from parents. They have gained prominence over the last few years for the prevention and detection of genetic disorders and cancer.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2009

Market Potential and Pitfalls

Genetic testing has gained immense prominence in the last few years for prevention as well as detection of genetic diseases and cancer. With the augmenting awareness among the global population associated with the early diagnosis, the market for genetic testing is estimated to propel during the appraisal period. Several technological advancements have been made in this field which offers enhanced accuracy and efficiency. This is anticipated to fuel the market growth during the assessment period. Moreover, the adoption of non-invasive genetic testing technology is likely to generate revenue for the market in the coming years. The increased demand from patients for personalized medicines is also anticipated to trigger the demand for genetic testing in the coming years. Personalized medicines provide tailored medical treatment to the patients based on the molecular basis. Developed economies like Europe undergo genetic testing in order to detect several rare and genetic diseases. Detection at an early stage enables early treatment and reduces the severity of the disease.

Technological advancements in genetic testing have also triggered the market growth across the globe. With the availability of new tests and advancements in the testing techniques, the demand for genetic testing has propelled across the world. Innovations in tests offering efficient and safer techniques of the disease detection, surpassing the risk of miscarriage during early pregnancy stage are driving the genetic testing market growth throughout the estimated period.

On the contrary, the dearth of advanced infrastructure and experienced professionals in the underdeveloped as well as developing nations are some of the top barriers considered to vitiate the market growth in the coming years. Moreover, accessibility to quality healthcare especially in areas with the low resource is difficult to maintain due to the lack of proper infrastructure. Such factors are likely to restrain the market growth to a certain extent.

Global Genetic Testing Market: Segmental Analysis

The global genetic testing market has been segmented on the basis of type, method, type of test, and indication.

By mode of type, the global genetic testing market has been segmented into DTC genetic testing and prescribed genetic testing. Among these, the prescribed genetic testing is presumed to occupy the largest market share.

By mode of method, the global genetic testing market has been segmented into chromosomal genetic test, molecular genetic test/DNA test, and biochemical genetic test. Among these, the molecular genetic tests/DNA is likely to occupy the largest market share.

By mode of type of test, the global genetic testing market has been segmented into predictive test, diagnostic test, family DNA test, and others. Among these, the diagnostic test is predicted to account for the largest market share globally due to its widespread applications in various diseases.

By mode of indication, the global genetic testing market has been segmented into neurogenetic disorder testing, cancer testing, muscular dystrophies, autoimmune disorder testing, and others. Among these, cancer testing occupied the largest market share owing to the increasing prevalence of cancer across the globe.

Browse 140 Pages Premium Research Report Enabled with 174 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/genetic-testing-market-2009

Regional Insights

Geographically, the genetic testing market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the American region occupied the largest market share with 46.3% and is likely to retain a significant share in the coming years. The growth is credited to the augmenting adoption of advanced technologies, continuous innovation, and growing awareness regarding genetic testing in this region. Moreover, the rising prevalence of genetic diseases like Turner syndrome, cancer, spinal muscular atrophy, and neurofibromatosis has contributed to the market growth in this region.

The Asia Pacific region is predicted to experience the steepest rise in the market proliferation grabbing 10.1% CAGR during the appraisal period. Growth factors contributing to the market growth include raising awareness regarding the advantages of predictive testing coupled with the increasing adoption of advanced technology for clinical applications.

The European region is estimated to register a significant growth rate owing to the advancements made in genomic technology and increasing awareness among the global population regarding the benefits of genetic testing.

Industry Updates

Gene drive technology can eradicate malaria in our lifetime; science has moved a step further in killing malaria with mutant mosquitoes. Andrea Crisanti and Austin Burt for the last fifteen years have worked throughout the day in order to engineer the perfect mosquitoes. They want to perpetuate a modified gene, called gene driver in a certain mosquito population which will render females sterile unless the entire species is wiped off.

Competitive Dashboard

The prominent players operating the global genetic testing market are Bio-Rad Laboratories Inc. (U.S.), PerkinElmer Inc. (U.S.), Illumina Inc. (U.S.), Quest Diagnostics (U.S.), QIAGEN N.V. (Germany), Myriad Genetics (U.S.), and Abbott Laboratories (U.S.).

Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/2009

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genetic Testing Market Expected to Grow at a CAGR over 11.5% Till 2024 with Worldwide Top Venders like Abbott Laboratories, Bio-Rad Laboratories, Inc., Illumina Inc., Myriad Genetics, Inc., PerkinElmer Inc., QIAGEN N. V., Quest Diagnostics Incorporated Et here

News-ID: 1813716 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Gene

DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034" The DNA and Gene Cloning Services Market Size is valued
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period? The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal